Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-019769

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO, Chief Scientist Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Mar 26, 2017
Accepted (ET)
Mar 28, 2017 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 26, 2017F21,799$13.76D1,199,982D
Common StockF1Mar 27, 2017F27,480$14.27D1,172,502D
Common StockF1,F2Mar 26, 2017F6,704$13.76D803,081ISee footnote
Common StockF1,F2Mar 27, 2017F9,271$14.27D793,810ISee footnote
Common StockF3holding———7,461,594ISee footnote
Common StockF4holding———5,000ISee footnote
Common StockF5holding———200,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses